Gastric Cancer Clinical Trials

Image of UPMC Hillman Cancer Center, 5115 Centre Ave in Pittsburgh, United States.

ACTM-838 for Cancer

18+
All Sexes
Pittsburgh, PA
This trial is testing a new drug called ACTM-838 in patients with advanced solid tumors that have not responded to standard treatments. The study will be done in two parts: Part 1a will
Phase 1
Recruiting
Has No Placebo
UPMC Hillman Cancer Center, 5115 Centre Ave (+1 Sites)SVP, Clinical Development, MD, PhDActym Therapeutics, Inc.
Image of Washington University School of Medicine in Saint Louis, United States.

BG-68501 + Fulvestrant for Breast Cancer

18+
All Sexes
Saint Louis, MO
This trial is testing a new drug called BG-68501 in patients with advanced solid tumors to see if it is safe, how the body processes it, its effects on the tumor, and its initial
Phase 1
Recruiting
Has No Placebo
Washington University School of Medicine (+5 Sites)Study DirectorBeiGene
Image of Henry Ford Cancer-Detroit in Detroit, United States.

Sacituzumab Govitecan + Capecitabine for Gastrointestinal Cancer

18+
All Sexes
Detroit, MI
This trial is testing a new combination of drugs, sacituzumab govitecan and capecitabine, for patients with advanced gastrointestinal cancers that have not responded to standard treatments. Researchers
Phase 1
Recruiting
Has No Placebo
Henry Ford Cancer-DetroitGilead Sciences
View More